Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Earnings release
confidence 95%
filed 2026-09-28
EX-99.2
This exhibit is a press release announcing Inventiva's unaudited first-half 2026 financial results, including revenues (€20k vs €4.5M prior year), net loss (€69.5M vs €175.9M prior year), cash position (€166.1M plus €67.8M in deposits), and cash runway guidance through Q2 2027. The document explicitly states "Inventiva Reports Unaudited 2026 First-Half Financial Results" and provides detailed financial tables and operational metrics typical of an earnings release. Material to investors assessing the company's financial condition and runway.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-28
Item 1.01
Brixmor Property Group and Everview Partners entered into definitive agreements on September 27, 2026 to acquire Slate Grocery REIT in a $2.34 billion transaction, comprising a direct acquisition of 23 grocery-anchored shopping centers for $636 million and a joint venture acquisition of 92 additional centers for $1.71 billion. The transaction is expected to close in Q1 2027 and is immediately accretive to earnings.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-09-28
Item 5.02
William D. Rahm, a director of Brixmor and Founder and CEO of Everview Partners, advised on September 27, 2026 that he does not intend to stand for reelection to Brixmor's board at the 2027 Annual Meeting, contingent on consummation of the Slate Transaction.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-28
Item 2.03
Hut 8 closed a $1.07 billion four-year senior secured revolving credit facility on September 24, 2026, creating a new direct financial obligation. The facility provides committed bank liquidity at SOFR plus 150–200 basis points with security interests in substantially all company assets, expanding the company's capital structure and liquidity position for funding development and construction projects.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-28
EX-99.1
The exhibit announces the launch and commercial success of The9's AI-developed mobile game "The Greed of Man," which reached No. 1 on Hong Kong App Store and Google Play simulation charts following its September 24, 2026 launch. This represents a material operational milestone demonstrating the company's AI-powered game development strategy (the9bit platform) translating into a commercially viable product, with plans for mainland China expansion. While not a discrete M&A, financial obligation, or governance event, this product launch and market validation is a significant operational achievement that would affect a reasonable investor's assessment of The9's business execution and AI commercialization strategy.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 8.01
TransCode announced updated Phase 1a clinical trial data for TTX-MC138 showing a 71.4% stable disease rate, disease control extending through six months, and three patients progression-free at one year, with no dose-limiting toxicities. This is a material clinical milestone for a clinical-stage immuno-oncology company, demonstrating positive efficacy and safety signals that support advancement to Phase 2a trials. While not a traditional earnings release (the company is pre-revenue), this clinical data disclosure is a significant operational and strategic milestone that would affect investor assessment of the drug candidate's therapeutic potential.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-28
Item 7.01
The filing announces the launch of approximately $44.4 billion in aggregate principal amount of senior secured first lien and second lien notes to finance the WBD acquisition and repay existing debt. This is a material creation of new direct financial obligations through debt issuance, disclosed under Item 7.01 (Regulation FD Disclosure) with press release and pro forma financials as exhibits. The scale ($44.4 billion) and connection to the major acquisition make this clearly material to investors.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-28
EX-99.4
This exhibit presents unaudited pro forma condensed combined financial information for ASUR's acquisition of CPC Aeroportos, completed on September 1, 2026. The document explicitly discloses the acquisition of 100% of CPC Aeroportos for R$5.1 billion (approximately U.S.$992.2 million), financed with a U.S.$1,230 million bridge facility. The acquisition adds 20 airport concessions across Brazil, Ecuador, Costa Rica, and Curaçao, serving over 45 million passengers annually—a material expansion of ASUR's geographic footprint and asset base. This is a completed material acquisition requiring pro forma financial disclosure under Regulation S-X Article 11.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-28
Item 8.01
Burke & Herbert Financial Services Corp. is proposing to offer and sell $100 million in newly issued Fixed-to-Floating Rate Subordinated Notes due 2036, with a 10-year term and 5-year call option. The company filed a preliminary prospectus supplement on September 28, 2026, pursuant to its effective Form S-3 registration statement. This constitutes creation of a new direct financial obligation and is a material capital-raising event for the registrant.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-28
EX-99.1
The announcement discloses an Argentine government Administrative Decision approving a material rebalancing of CAAP's flagship concession agreement for Aeropuertos Argentina S.A., including a $7.3 billion capital investment program, extension of the concession term by 18 years (to February 2056), tariff adjustments, and an agreed IRR of 14.30%. This is a significant operational and strategic milestone affecting the company's largest asset and long-term cash flow profile, but does not fit the specific event categories (M&A, debt issuance, impairment, etc.); it is a material concession amendment and capital deployment plan.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-09-28
EX-99.1
Fairfax announces a Normal Course Issuer Bid (NCIB) to repurchase up to 2,025,315 Subordinate Voting Shares and 950,000 Series K Shares over a 12-month period. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category. The board's approval and the specific purchase limits (approximately 10% of public float) indicate a material capital allocation decision affecting shareholder value.
View raw filing on EDGAR →
6-K
Governance Other
confidence 70%
filed 2026-09-28
EX-99.1
Amber International Holding Ltd scheduled an annual general meeting for October 23, 2026, to seek shareholder approval of multiple governance matters: appointment of Michael Wu as chairman and four other directors, approval of a material one-off incentive share award of 23.5 million Class B shares to founder Michael Wu (which would increase his voting power from 74.1% to 82.3%), and confirmation of the Post-IPO Share Incentive Plan with increased share reserves.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-28
EX-99.1
This news release announces the successful energization and permanent grid power connection of the Skouries mine in Greece, a major operational milestone. The company states this "is an important step in advancing Skouries toward ramp up to steady-state operations" and "supports the continued advancement of processing and mining activities as the project progresses toward commercial production expected in the fourth quarter of 2026." While not a discrete event type like M&A or exec change, this represents a material operational achievement for a development project transitioning toward production, affecting investor assessment of project execution and timeline.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-28
Item 8.01
Ford Credit Auto Receivables Two LLC filed this 8-K to disclose the issuance of asset-backed securities (Notes) by Ford Credit Auto Owner Trust 2026-C pursuant to a prospectus dated September 22, 2026. The filing includes legality and tax opinions from counsel, which are standard documentation for a debt issuance. This represents the creation of a new direct financial obligation through the issuance of Notes, fitting the debt_issuance category.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 8.01
The filing discloses a conditional notice of redemption of $350 million in senior notes, with the redemption explicitly conditioned upon the "substantially concurrent consummation" of a previously announced merger between Dream Finders Homes and Beazer Homes. The merger agreement is dated August 6, 2026, and the redemption is tied directly to the merger closing on October 20, 2026. This is a material acquisition event (Beazer becoming a wholly owned subsidiary of Dream Finders) disclosed under Item 8.01, with the debt redemption being a financing consequence of the change of control.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 8.01
This Item 8.01 disclosure centers on Kimberly-Clark's commencement of exchange offers and consent solicitations in connection with its "previously announced pending acquisition" of Kenvue Inc., expected to close in Q4 2026. The filing describes the mechanics of exchanging up to $7 billion of Kenvue Notes for Kimberly-Clark Notes and cash, along with proposed amendments to Kenvue's indenture. While technically filed under Item 8.01 (Other Events), the substance is a material acquisition activity—specifically, the financing and debt restructuring component of a major M&A transaction that would materially affect the registrant's capital structure and financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-28
Item 3.02
Eagle Point Trinity Senior Secured Lending Co issued 910.51 common shares for $9,325 in aggregate proceeds pursuant to subscription agreements, with the offer and sale exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-09-28
Item 8.01
Kyndryl entered into an Underwriting Agreement on September 24, 2026 to issue $600 million of 7.800% Senior Notes due 2029 and $400 million of 7.875% Senior Notes due 2032, creating $1 billion in new direct financial obligations. The company intends to use proceeds to repay maturing debt and revolving credit facilities. This is a material debt issuance under Item 2.03 taxonomy, distinct from refinancing activity or covenant breach.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-09-28
Item 5.02
The filing discloses both the resignation of Gianluca Fuggetta as principal financial officer (effective September 30, 2026) and the appointment of Gene Mack as interim Chief Financial Officer (effective October 1, 2026). While both events occur, the principal disclosed action centers on the appointment of Mack to assume the duties of principal financial officer and principal accounting officer. The appointment of an interim CFO is material to investors as it signals a change in financial leadership and potential operational continuity concerns, particularly given the company is conducting an ongoing search for a permanent replacement.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-28
Item 8.01
The filing discloses that SilverBox Corp IV's units, Class A ordinary shares, and warrants have been delisted from the New York Stock Exchange effective September 28, 2026, and are now quoted and traded on the OTC Markets under new ticker symbols (SBXUF, SBXDF, SBXWF). This is a material delisting event that materially affects the registrant's listing status and liquidity, even though the company intends to remain a public reporting company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-28
Item 2.02
AAR CORP issued a press release on September 28, 2026 reporting financial results for the first quarter ended August 31, 2026, disclosing sales of $918 million (24% increase), GAAP diluted EPS of $1.00, and adjusted diluted EPS of $1.49 (38% increase). This is a standard quarterly earnings release attached as Exhibit 99.1 to Item 2.02 of the 8-K, which is the typical disclosure vehicle for earnings announcements.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-28
Item 8.01
Ameren Missouri filed its 2026 Integrated Resource Plan (IRP) with the Missouri Public Service Commission on September 28, 2026, outlining a comprehensive long-term energy strategy involving substantial capital investments in natural gas, renewables, battery storage, and nuclear generation, along with coal retirement plans. This is a material operational and strategic disclosure affecting the company's future capital allocation, generation mix, and regulatory standing, but does not fit the specific categories of M&A, debt issuance, impairment, or other defined event types—making it an operational/strategic milestone best classified as operational_other.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 1.01
Clearway Energy's subsidiary (Swan Purchaser LLC) entered into a Membership Interest Purchase Agreement to acquire membership interests in Swan TargetCo LLC, which will own Swan Solar—a 650 MW solar photovoltaic facility under development in Missouri. The transaction is valued at approximately $230 million in cash (subject to adjustments), constituting a material acquisition of a significant renewable energy asset. This is a classic M&A disclosure under Item 1.01 involving entry into a material definitive agreement for an asset acquisition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 1.01
This disclosure describes entry into a material definitive agreement for acquisition of membership interests in Swan TargetCo LLC, which will own Swan Solar, a 650 MW solar facility under development in Missouri. The transaction is valued at approximately $230 million in cash with closing expected in Q3 2028. This constitutes a material acquisition under Item 1.01 and would materially affect a reasonable investor's assessment of the company's capital deployment and asset portfolio.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-28
EX-99.1
This exhibit announces Quantum eMotion's entry into a definitive arrangement agreement to acquire 100% of Plurilock Security Inc. for approximately C$33.8M in mixed cash and stock consideration (C$0.084 cash + 0.0763 QeM shares per Plurilock share). The transaction is structured as a court-approved plan of arrangement under British Columbia law, with completion subject to shareholder and regulatory approvals. This is a material acquisition that would significantly expand QeM's commercial cybersecurity platform and customer base.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-28
Item 1.01
AAR CORP entered into a definitive Share Purchase Agreement on September 28, 2026, to acquire a 65% controlling interest in MRO Holdings for an implied enterprise value of $4.0 billion, consisting of approximately $1.82 billion in cash and $780.8 million in Series A Convertible Preferred Stock, with an option to acquire an additional 5% at any time. The transaction is expected to close in fiscal Q3 2027 and will significantly expand AAR's aviation aftermarket platform, adding over $1 billion in annual revenue and enhancing EBITDA margins from 12% to 16% before synergies.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 8.01
The disclosure announces clinical trial progress on REO 033, a randomized colorectal cancer study, including site activation completion, enrollment acceleration, and FDA alignment on a potential accelerated approval pathway. This is a material operational/clinical milestone for a clinical-stage biotech company, but does not fit the specific categories of earnings release, exec changes, M&A, restatement, auditor change, going concern, impairment, shareholder vote, delisting, bankruptcy, covenant breach, cybersecurity, dilutive issuance, litigation, debt issuance, dividend, or workforce reduction. The event is clearly operational (clinical development progress) rather than financial, governance, legal, or existential in nature.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-28
Item 1.01
FTAI Infrastructure Inc.'s subsidiary Drub LLC entered into a definitive Membership Interest Purchase Agreement to acquire all membership interests of DRUbit, a crude oil logistics company with assets including the Port Arthur Terminal and a 50% interest in the Diluent Recovery Unit, for approximately $255 million enterprise value. The acquisition is expected to generate approximately $50 million in annual EBITDA, more than doubling Jefferson's existing EBITDA, and will be financed through assumed debt of approximately $190 million and a $72 million debt commitment from Barclays.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-28
Item 1.01
Lifecore Biomedical entered into a definitive Agreement and Plan of Merger with Webster Equity Partners affiliates on September 27, 2026, whereby the Company will become a wholly owned subsidiary of Parent. Common stockholders will receive $6.28 per share in cash plus contingent value rights, with total consideration up to $663.7 million assuming full CVR achievement, subject to stockholder approval and regulatory clearance with expected closing in Q4 2026.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-28
EX-99.1
This press release announces an amendment to a binding commercial offtake agreement with Trafigura that increases the optional volume commitment from 8,000 to 12,000 metric tonnes per year of lithium carbonate for the South West Arkansas Project. The disclosure is material because it represents a significant commercial milestone—exceeding the 80% offtake target (20,000 of 22,500 tonnes) and enabling the company to proceed with $1.1 billion in project debt financing and a targeted Final Investment Decision later in 2026. While this is a strategic business development rather than a discrete event like M&A or a financial obligation, it is clearly operational in nature and material to investors assessing the project's viability and financing path.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-28
EX-99.1
This press release discloses an operational update for the Goose Mine (commissioning of a new mobile crushing plant, Phase 1 upgrades to fixed crushing plant, and reaffirmation of 2026 production guidance of 170,000–200,000 ounces) and exploration drilling results at the Back River Gold District. The operational update addresses recovery from a fire damage event and demonstrates progress toward production targets. The exploration results (drill intercepts at Llama, Nuvuyak, Tattuk, and Locale 1) support future mine planning and resource conversion. While not a discrete M&A, financing, or governance event, the operational progress and exploration findings are material to investors' assessment of the company's ability to execute its production plan and extend mine life.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-28
EX-99.1
This press release announces shareholder approval of Intermap's acquisition of the remaining shares of PCI Geomatics Group Inc. ("CATALYST"), with closing expected mid-October 2026. The disclosure explicitly states that PCI shareholders approved the Arrangement Resolution with overwhelming majorities (99.99% and 100% across share classes), and the transaction is subject only to court approval and satisfaction of closing conditions. This is a material acquisition activity under Item 1.01 / 2.01 of the 8-K taxonomy, as it represents a significant change of control and combination of two geospatial intelligence companies.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-09-28
EX-99.1
The press release announces the record date (September 28, 2026), ex-dividend date (October 6, 2026), and distribution date (October 5, 2026) for a previously-announced stock dividend of 0.50 common shares per common share outstanding. This is a material capital distribution to shareholders that would affect a reasonable investor's assessment of the registrant's capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 1.01
SCYNEXIS entered into a material contract with BARDA providing up to $214 million in non-dilutive federal funding to support development of SCY-247, a second-generation antifungal candidate through NDA submission for two indications. This strategic partnership strengthens the company's pipeline, accelerates development of a Phase-2-ready program, and extends cash runway into 2029.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-28
EX-99.1
Kenon's subsidiary OPC Energy has entered into an agreement to sell its distributed energy business (approximately 52.2 MW of natural-gas-fired generation facilities) to a subsidiary of Aluma Infrastructure Fund for approximately NIS 272 million (~$90 million). This is a material disposition of a business unit that would affect a reasonable investor's assessment of Kenon's asset base and cash position. The transaction is subject to conditions precedent including Israel Competition Authority approval within 180 days.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-09-28
The filing discloses a shareholder demand letter from S.H.N. Financial Investments Ltd. (holding ~5.7% of voting rights) requesting a special general meeting to remove non-external directors and appoint three S.H.N. nominees. This is a governance event involving potential board composition changes and shareholder activism, but does not fit the specific categories of exec_departure, exec_appointment, or shareholder_vote_results (no vote has occurred yet). The material threat to board control makes this a governance matter that would affect investor assessment.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-28
Item 7.01
This disclosure reports positive preclinical findings for SIL204 demonstrating a key cellular uptake mechanism via native lipoprotein pathways. While framed as a Regulation FD disclosure (Item 7.01), the substance is a material operational/scientific milestone supporting the company's Phase 2/3 clinical development program. The findings validate a core mechanism of action and provide mechanistic support for systemic administration strategy, which would materially affect investor assessment of the lead candidate's therapeutic potential and clinical viability. This is operational progress rather than a specific event type (not earnings, M&A, litigation, etc.), making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-09-28
EX-99.1
Einat Zakariya resigned as a director and member of all board committees effective September 27, 2026, for personal reasons. This is a clear executive departure — the principal disclosed action is a board member leaving office. The resignation of a director is material to investors' assessment of governance and board composition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-28
EX-99.1
Maris-Tech announced receipt of a US$10 million order for advanced video systems for next-generation airborne defense platforms, with potential follow-on orders bringing total value to approximately US$14.1 million. This is a material contract award representing the company's "largest-ever contract," but it is not a discrete M&A transaction, financing event, or other specifically-named event type. The disclosure is clearly operational—a significant customer contract and strategic partnership with Magam—making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-28
Item 3.02
On September 25, 2026, Jaguar Health exchanged 481,584 shares of common stock for a $3.4 million reduction in the outstanding balance of a secured promissory note originally issued in 2021. The shares were issued as unregistered securities under Section 3(a)(9) of the Securities Act, representing a dilutive equity issuance that materially affects the company's capital structure and shareholder equity.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
Flutter has ceased operations in Brazil following a provisional executive order banning online betting and gaming. The disclosure quantifies material financial impact ($70m revenue reduction, $20m EBITDA reduction for 2026) and notes significant non-cash accounting implications related to $539m goodwill and $252m in intangible assets. While this involves a major operational shutdown with substantial financial consequences, it is fundamentally an operational/regulatory event—the cessation of business in a jurisdiction—rather than a specific financial event type (impairment, debt covenant, etc.), making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-09-28
EX-99.1
This Appendix 2A filing discloses the conversion of 106,175 employee performance rights (NVX:AD) into 74,694 ordinary fully paid shares (NVX) on 28 September 2026. While the immediate dilution from this single conversion event is modest (~0.007% of outstanding shares), the filing reveals substantial unquoted convertible securities on issue (45.2M convertible notes, 35M convertible debentures, 20.6M performance rights, 14M options), creating material future dilution risk. The conversion of equity-linked securities and the disclosure of the company's significant convertible capital structure would affect a reasonable investor's assessment of dilution exposure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-28
Item 3.02
Valley National Bancorp entered into a definitive Agreement and Plan of Merger to acquire Bluevine Inc. for approximately $340 million in aggregate consideration, comprising approximately $255 million in cash and approximately 6.3 million shares of Valley common stock. The transaction is expected to close in early 2027 subject to regulatory approvals and aligns with Valley's strategic priorities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-28
Item 8.01
Strategy Inc sold 1,469,165 shares of Class A Common Stock under an at-the-market offering program, generating $246.2 million in net proceeds. The proceeds were deployed for bitcoin purchases and preferred stock repurchases, representing a material capital-raising activity that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-28
Item 8.01
The disclosure reports enrollment of first patients in the Phase 3 4SIGHT clinical trial for 4D-150 in diabetic macular edema and release of 2-year SPECTRA trial data showing favorable safety and efficacy results. This is a material clinical development milestone for a biopharmaceutical company's lead product candidate, demonstrating progress toward regulatory approval and commercialization. The event is operational/strategic in nature—a significant clinical advancement—rather than fitting a specific financial, governance, or legal category.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 8.01
Fate Therapeutics received a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support the Phase 2 RECLAIM-LN clinical trial of FT819. This is a material operational and strategic event—a significant external funding award that advances the company's clinical development program for a potentially registrational trial in lupus nephritis. While not a traditional earnings release, M&A activity, or governance matter, this grant materially supports the company's pipeline advancement and is disclosed as a press release in Item 8.01 (Other Events), making it an operational milestone rather than a routine administrative disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-28
The 6-K discloses the results of MakeMyTrip's annual shareholders' meeting held on September 28, 2026, stating that "all of the resolutions submitted to MakeMyTrip's shareholders at the above meeting were duly approved and passed." This is a direct disclosure of shareholder vote results, which is a material governance event that investors rely upon to understand the outcome of corporate actions put to a vote.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 8.01
Kodiak announced that primary endpoints were met for both Zenkuda and tabirafusp-ted in the Phase 3 DAYBREAK study in wet AMD, with Zenkuda demonstrating strong efficacy and durability (54% of patients on 6-month dosing). The company plans to submit a multi-indication BLA in Q4 2026. This is a material clinical milestone for a precommercial biotech company advancing toward regulatory approval and commercialization, but it is not a financial result (earnings_release), M&A activity, or other specifically-named event type—it is a major operational/clinical development milestone.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-28
Item 1.01
Getty Realty Corp. completed the acquisition of 41 convenience store properties for approximately $260.9 million through a sale-leaseback transaction with Refuel Operating Company and Blue Horseshoe 2, LLC, consummated on September 22, 2026. The transaction represents a significant capital deployment and material expansion of the company's real estate portfolio across five states.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-09-28
Item 2.03
Churchill Downs closed a $500 million senior secured Term Loan B due 2033 at SOFR plus 175 basis points and amended its existing senior secured credit agreement to extend the maturity of its revolving credit facility and Term Loan A from 2029 to 2031. Proceeds will be used to repay existing term loan B-1 loans, revolving loans, transaction fees, and general corporate purposes.
View raw filing on EDGAR →